73 related articles for article (PubMed ID: 21830438)
1. Differences in prognostic factors between early and advanced gastric cancer.
Kim BS; Cho SW; Min SK; Lee BH
Hepatogastroenterology; 2011; 58(107-108):1032-40. PubMed ID: 21830438
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in early gastric cancer.
Kunisaki C; Shimada H; Takahashi M; Ookubo K; Moriwaki Y; Akiyama H; Nomura M
Hepatogastroenterology; 2001; 48(37):294-8. PubMed ID: 11268989
[TBL] [Abstract][Full Text] [Related]
5. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
6. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein in gastric carcinomas is not independently prognostic.
Motojima K; Furui J; Kohara N; Ito T; Kanematsu T
Surgery; 1994 Nov; 116(5):890-5. PubMed ID: 7940194
[TBL] [Abstract][Full Text] [Related]
8. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients.
Shin SH; Bae JM; Jung H; Choi MG; Lee JH; Noh JH; Sohn TS; Kim S
J Surg Oncol; 2010 Apr; 101(5):384-8. PubMed ID: 20127892
[TBL] [Abstract][Full Text] [Related]
11. [Early gastric cancer. Survival and prognostic factors in 95 consecutive cases].
Iuliano R; Arrigoni A; Recchia S; Andriulli A; Canavese V; Rodinò S; Giglio A; Verme G
Minerva Gastroenterol Dietol; 1991; 37(4):205-9. PubMed ID: 1805972
[TBL] [Abstract][Full Text] [Related]
12. Macroscopic appearance and biological character of gastric cancer invading the muscularis propria.
Ichiyoshi Y; Tomoda M; Tomisaki S; Oda S; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1996; 43(9):553-9. PubMed ID: 8799394
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up in early gastric cancer: evaluation of prognostic factors.
Ranaldi R; Santinelli A; Verdolini R; Rezai B; Mannello B; Bearzi I
J Pathol; 1995 Dec; 177(4):343-51. PubMed ID: 8568588
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing survival in advanced gastric cancer.
Tabuenca AD; Aitken DR; Ihde JK; Smith J; Garberoglio C
Am Surg; 1993 Dec; 59(12):855-9. PubMed ID: 8256943
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of the prognostic significance of DNA ploidy patterns in gastric cancer.
Tirindelli Danesi D; Cucchiara G; Picconi A; Daffinà M; Fabiano A; Antonini F; Toscano MG; Pasqualetti P; Altavista P; Cordelli E; Spanò M
Eur J Histochem; 1997; 41 Suppl 2():147-8. PubMed ID: 9859824
[No Abstract] [Full Text] [Related]
16. Mutated p53 in tumors, mutant p53 and p53-specific antibodies in the circulation in patients with gastric cancer.
Maeta M; Saito H; Oka S; Tsujitani S; Ikeguchi M; Kaibara N
J Exp Clin Cancer Res; 2000 Dec; 19(4):489-95. PubMed ID: 11277328
[TBL] [Abstract][Full Text] [Related]
17. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
Isozaki H; Tanaka N; Okajima K
Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
[TBL] [Abstract][Full Text] [Related]
18. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of clinicopathologic parameters and prognosis of gastric carcinoma between different phases].
Cai SR; Chen CQ; Ma JP; Chen JH; Song W; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1264-8. PubMed ID: 19595182
[TBL] [Abstract][Full Text] [Related]
20. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
